Association between unmetabolized folic acid and breast cancer incidence in MTHFR C677T polymorphism

Abstract
Objectives: Carriers of the C677T have both altered folate metabolism
and higher risk of cancers, including breast cancer. Supplementation is
thought to correct his imbalance, but high intakes of synthetic folic acid
increase blood concentrations of unmetabolized folic acid (UFA) with
unknown implications on breast cancer risk, particular among those with
altered folate metabolism. This study assesses the association between
plasma UFA and breast cancer among MTHFR C677T genotypes.

Methods

Participants

Results

Participants for the case population will be recruited by advertisement and
provider reference at three breast cancer clinics in the D.C. metropolitan
area while controls will be recruited by advertisement at adjoining hospital
centers. Subjects will be excluded if they are currently pregnant, lactating,
taking any medication or undergoing any treatment that might interfere
with folate metabolism. For the control population, additional exclusion
criteria is a history of breast cancer.

A cohort of 150 adult females with histologically confirmed breast
cancer will be recruited via advertisement and referral at three
breast cancer clinics; one in Washington, D.C., Maryland, and
Virginia. 150 adult female controls, without a history of breast
cancer will be recruited via advertisement placed in adjoining
hospitals.

Recruited subjects will undergo a brief interview with a healthcare
professional to ascertain biometrics (age, weight, height, race, menopausal
status), medical history, reproductive data, and potential confounding
variables (e.g. alcohol consumption). After 8 hours of fasting or more,
subjects will provide venous blood samples from which genotyping and
UFA may be measured.

Participants who complete the full questionnaire, interview, and
provide a blood sample will then receive explanation of
compensation and reimbursement for their participation in the
study. Participants will be provided $80.00 USD for both days of
participation, reimbursement of travel costs to and from the
hospital (up to $20.00 per day for roundtrip costs), with an
additional $50.00 USD upon the provision of the blood sample.

Quantitative data from the study are the plasma UFA levels
stratified by genotype and breast cancer status. Differences in
characteristics of cases and controls will be analyzed using a
Student’s t-test while distribution of covariates will be tested via
Chi-square test. Analyses for the interaction of genotype and UFA
with breast cancer will be stratified by genotype (CC, CT, TT) and
odds ratio (and 95% confidence interval) for breast cancer in
relation to UFA calculated with conditional logistic regression to
preserve matching.

Methods: In this hospital-based case-control study, 150 adult women
with confirmed history of breast cancer were age-matched to 150 adult
female controls. Blood concentration of unmetabolized folic acid was
determined via fasting venous blood samples and the effects of UFA on
breast cancer incidence were assessed by conditional logistic regression.

Results: Stratified by genotype, we expect a small but statistically
significant increased odds ratio associated with higher UFA among
homozygous MTHFR C677T polymorphs and a non-statistically
significant association among heterozygous genotypes between
UFA and breast cancer risk. We expect to find no association of
UFA and breast cancer in wild-types.

Objectives
The U.S. folic acid enrichment program has been effective in raising
population average levels of folate intake and, as a consequence, in
reducing incidence of neural tube defects (NTD). But, within a few years,
folate intake in the population far exceeded the amount estimated prior to
implementing the folic acid enrichment program and evaluated for safety.
Though it was generally believed these high intakes of folic acid were
relatively harmless, research increasingly shows that folate plays a
complex and potentially dual role in cancer: where too little may increase
risk for carcinogenesis, but excessive levels may promote cancer growth.
Given that women of child-bearing age are the primary target of folic acid
enrichment, this potential role of folate in breast cancer has been
increasingly investigated among carriers of the common MTHFR C677T
mutation, present in upwards of 40% of the population. However, few of
these studies have sought to illuminate the potential differing affects of
natural versus synthetic folate. As unmetabolized folic acid is almost
exclusively a function of folic acid intake, the present study hopes to
demonstrate whether high folic acid intake is associated with breast cancer
in MTHFR C677T polymorphs through the association between UFA and
breast cancer among the genotypes.

Prevalence of UFA in relation to FA intake 4

By correlating UFA concentrations with breast cancer incidence in the
MTHFR genotypes, this study aims to illustrate the potential differing
affects that synthetic folate (folic acid) may have on breast cancer risk in
women with altered folate metabolism via the MTHFR mutation, as
compared with the risks posed by elevated folate intake from dietary
sources.

The Folate Metabolism Cycle

Discussion
It is expected that this cohort study will show a small, but
statistically significant association between UFA and breast cancer
among homozygous (TT) MTHFR C677T genotypes and a nonsignificant association among heterozygous (CT) types.
Such results provide evidence of potential harm from very elevated
intakes of synthetic folates among carriers of this mutation and
would warrant further investigation into risks associated with folic
acid supplementation, renewed scrutiny of the safety of mandatory
folic acid enrichment, and research into the possible suitability of
substituting synthetic folic acid with natural 5-MTHF in enrichment
and supplementation programs.
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